Scarica l'app Stockscreener
28.33
1.76%
0.49
Dopo l'orario di chiusura:
28.40
0.07
+0.25%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ROIV Giù?
Forum
Previsione
Roivant Sciences Ltd Borsa (ROIV) Ultime notizie
Roivant Sciences Ltd. (ROIV) Discusses Brepocitinib Program Expansion and Phase III Batoclimab Data UpdateSlideshow (NASDAQ:ROIV) 2026-04-04 - Seeking Alpha
ROIV PE Ratio & Valuation, Is ROIV Overvalued - Intellectia AI
ROIV | Roivant Sciences Ltd. Common Executive Compensation - Quiver Quantitative
Roivant Sciences (ROIV) Is Up 6.8% After Mixed Autoimmune Trial UpdatesHas The Bull Case Changed? - simplywall.st
Roivant Sciences Ltd. (ROIV) stock price, news, quote and history - Yahoo Finance UK
Roivant Sciences Ltd. Experiences Revision in Stock Evaluation Amid Strong Market Performance - Markets Mojo
Should Brepocitinib’s New Trials and Batoclimab’s Setback Require Action From Roivant Sciences (ROIV) Investors? - Yahoo Finance
Roivant (NASDAQ: ROIV) executive settles RSU taxes with shares - Stock Titan
Immunovant Batoclimab Flops in Phase 3 TED as Roivant Expands Brepocitinib Into LPP - Yahoo Finance
Roivant Shrugs Off Batoclimab Phase III Failure in TED - Citeline News & Insights
Roivant Sciences Adds Brepocitinib LPP Trial as Batoclimab Misses Phase III TED Endpoint - Yahoo Finance
Roivant (Nasdaq: ROIV) shows $4.3B cash and mixed late-stage trial results - Stock Titan
Scarring hair-loss disease gets drug trial with no approved therapy - Stock Titan
Roivant Sciences (ROIV) executive settles CVARs and RSUs into shares - Stock Titan
Roivant Sciences Ltd. (ROIV) Stock Forecasts - Yahoo Finance
(ROIV) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Movement Recap: Is Roivant Sciences Ltd forming a bullish divergence2026 Patterns & Long-Term Capital Growth Strategies - baoquankhu1.vn
CEO Change: Is Roivant Sciences Ltd a potential multi bagger2026 Pullbacks & Free Expert Approved Momentum Trade Ideas - baoquankhu1.vn
Volume Summary: Is Roivant Sciences Ltd stock risky to hold now2026 Retail & Community Consensus Stock Picks - baoquankhu1.vn
250,468 Shares in Roivant Sciences Ltd. $ROIV Acquired by Exchange Traded Concepts LLC - MarketBeat
Roivant Sciences Insider Sold Shares Worth $1,921,500, According to a Recent SEC Filing - MarketScreener
Roivant Sciences Ltd (ROIV) Stock Price Quote Today & Current Price Chart - Capital.com
Roivant Sciences Ltd (ROIV) Stock Price Quote Today & Current Price Chart | Capital.com Australia - Capital.com
Roivant Sciences (NASDAQ: ROIV) director exercises 70K options, sells 70K shares - Stock Titan
Aug Sentiment: Is Roivant Sciences Ltd backed by strong institutional buyingStock Surge & Free Growth Oriented Trading Recommendations - baoquankhu1.vn
Assessing Roivant Sciences (ROIV) Valuation After Brepocitinib Priority Review And Phase 3 VALOR Success - Sahm
Cantor Fitzgerald reiterates Roivant Sciences stock rating By Investing.com - Investing.com India
Gains Recap: Should I hold or sell Roivant Sciences Ltd nowMarket Weekly Review & AI Driven Stock Movement Reports - baoquankhu1.vn
Sentiment Watch: Is Roivant Sciences Ltd a potential multi bagger2026 Decliners & High Accuracy Swing Entry Alerts - baoquankhu1.vn
ROIV Technical Analysis & Stock Price Forecast - Intellectia AI
Bernstein initiates coverage of Roivant Sciences Ltd. (ROIV) with an outperform rating - MSN
New England Journal of Medicine publishes positive phase 3 valor trial results of brepocitinib in dermatomyositis - marketscreener.com
NEJM study: rare muscle-skin disease drug beat placebo in Phase 3 - Stock Titan
New England Journal of Medicine Publishes Positive Phase 3 VALOR Trial Results of Brepocitinib in Dermatomyositis - Sahm
Aug Ideas: Whats the fair value of Roivant Sciences Ltd stockTrade Exit Report & Community Verified Watchlist Alerts - baoquankhu1.vn
Should Roivant’s Moderna Settlement Shift Investor Focus to Pipeline Execution Risks for Roivant Sciences (ROIV)? - simplywall.st
Can Roivant Sciences Ltd sustain earnings growthEarnings Performance Report & AI Forecasted Stock Moves - baoquankhu1.vn
Big Money Moves: Can Roivant Sciences Ltd sustain earnings growthProduct Launch & Weekly Watchlist for Hot Stocks - baoquankhu1.vn
Vanguard realignment leads to separate reports for Roivant (ROIV) - Stock Titan
Bernstein Initiates Coverage of Roivant Sciences Ltd. (ROIV) with an Outperform Rating - Insider Monkey
Roivant Sciences (ROIV) CFO reports RSU tax-withholding of 1,546 shares - Stock Titan
Assenagon Asset Management S.A. Purchases 6,877,348 Shares of Roivant Sciences Ltd. $ROIV - marketbeat.com
12 Best UK Stocks to Buy According to Hedge Funds - Insider Monkey
Roivant Sciences, Genevant, Arbutus, and Moderna Settle International Patent Litigation – Key Terms and Confidentiality Details - Minichart
Roivant Sciences (ROIV) soars 19.4% as pipeline drugs progress - MSN
Roivant secures FDA priority review for dermatomyositis treatment - MSN
Risk Analysis: Is Roivant Sciences Ltd backed by strong institutional buyingBreakout Watch & High Conviction Investment Ideas - baoquankhu1.vn
Roivant Sciences Ltd. (NASDAQ:ROIV) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
(ROIV) Risk Channels and Responsive Allocation - Stock Traders Daily
Bernstein initiates Roivant Sciences stock with outperform rating By Investing.com - Investing.com Australia
Bernstein initiates Roivant Sciences stock with outperform rating - Investing.com
Sanford C. Bernstein Begins Coverage on Roivant Sciences (NASDAQ:ROIV) - MarketBeat
Roivant Sciences Insider Sold Shares Worth $5,648,000, According to a Recent SEC Filing - marketscreener.com
Roivant Sciences (NASDAQ:ROIV) CEO Sells 200,000 Shares - MarketBeat
Roivant (NASDAQ: ROIV) president exercises 200K options and sells 200K shares - Stock Titan
Trade Recap: What is the dividend yield of Roivant Sciences LtdShort Setup & AI Based Trade Execution Alerts - baoquankhu1.vn
Roivant Sciences Insider Sold Shares Worth $1,200,573, According to a Recent SEC Filing - marketscreener.com
0.16%
1.47%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):